<DOC>
	<DOCNO>NCT00158990</DOCNO>
	<brief_summary>The purpose project determine whether concurrent treatment patient major depression ( unipolar bipolar ) triiodothyronine ( T3 ) sertraline , lead strong and/or rapid antidepressant effect treatment sertraline alone .</brief_summary>
	<brief_title>Triiodothyronine ( T3 ) Supplementation Treatment Bipolar Unipolar Depression .</brief_title>
	<detailed_description>AIM : To determine therapeutic efficacy adverse effect triiodothyronine ( T3 ) supplement treatment bipolar depression ( BPD ) mood stabilizer ( MS ) ( lithium - Li , valproic acid - VPA carbamazepine - CBZ ) specific serotonin reuptake inhibitor ( SSRI ) , sertraline ; supplement treatment unipolar depression ( UPD ) sertraline . METHOD : A random assignment , double blind , placebo-controlled trial separately evaluate patient ) BPD treat MS + sertraline + T3 MS + sertraline + placebo b ) UPD treat sertraline + T3 sertraline + placebo , 8 week case . The design trial permit outcome treatment speed response evaluate .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>1 . Diagnosis Major Depressive Episode ( MDE ) context Bipolar Disorder I II ( BPDI BPDII ) Major Depressive Disorder ( UPD ) , accord DSMIV criterion , without psychotic feature . 2 . Hamilton Depression Scale ( HAMD ) total &gt; 16 item 1 ( depressed mood ) &gt; 2 . 3 . Age 1870 year , male female . 4 . Competent willing give write informed consent . 1 . No clinical hyper hypothyroidism thyroid illness . 2 . No neurological physical illness may impact upon study limit prescription study medication . 3 . No lifetime history substance alcohol dependence abuse precede 12 month . 4 . No significant suicidal risk ( HAMD item 3 ( suicide ) &lt; 3 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>major depression</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>unipolar depression</keyword>
	<keyword>sertraline</keyword>
	<keyword>triiodothyronine</keyword>
</DOC>